STOCK TITAN

Saba Capital adds to Gabelli Healthcare (NYSE: GRX) stake

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 7,087 shares of Common Stock in an open-market or private transaction on 2026-08-21 at $10.13 per share. After this transaction, Saba Capital Management, L.P. indirectly holds 2,150,793 shares of GRX Common Stock.

Positive

  • None.

Negative

  • None.
Insider Saba Capital Management, L.P.
Role 10% Owner
Bought 7,087 shs ($72K)
Type Security Shares Price Value
Purchase Common Stock 7,087 $10.13 $72K
Holdings After Transaction: Common Stock — 2,150,793 shares (Indirect, -)
Shares purchased 7,087 shares of Common Stock Open-market or private purchase on 2026-08-21
Purchase price per share $10.13 per share Price reported for 7,087-share purchase on 2026-08-21
Shares owned after transaction 2,150,793 shares of Common Stock Indirect holdings of Saba Capital Management, L.P. following the purchase
Form type Form 4 Statement of changes in beneficial ownership filed for GRX
Insider status Ten percent owner Status of Saba Capital Management, L.P. with respect to GRX
ten percent owner regulatory
"Saba Capital Management, L.P. is reported as a ten percent owner"
indirect ownership regulatory
"The transaction is reported with ownership type indirect (code I)"
Common Stock financial
"The transaction involves 7,087 shares of Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open market or private transaction regulatory
"Transaction code P denotes a purchase in open market or private transaction"

FAQ

What insider transaction did Saba Capital report for GRX?

Saba Capital Management, L.P. reported a purchase of 7,087 GRX Common Stock shares on 2026-08-21 at $10.13 per share, increasing its indirect holdings to 2,150,793 shares.

Is Saba Capital a major holder of Gabelli Healthcare & WellnessRx Trust (GRX)?

Yes. Saba Capital Management, L.P. is identified as a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX) in this Form 4 filing.

How many GRX shares does Saba Capital own after the latest transaction?

Following the 7,087-share purchase reported on 2026-08-21, Saba Capital Management, L.P. indirectly holds 2,150,793 shares of Gabelli Healthcare & WellnessRx Trust (GRX) Common Stock.

What was the price paid per share in Saba Capital’s GRX purchase?

Saba Capital Management, L.P. reported paying $10.13 per share for 7,087 shares of Gabelli Healthcare & WellnessRx Trust (GRX) Common Stock on 2026-08-21.

Was the GRX transaction by Saba Capital a buy or a sell?

The Form 4 shows a purchase of Gabelli Healthcare & WellnessRx Trust (GRX) Common Stock by Saba Capital Management, L.P., coded as a “P” transaction, indicating a buy in an open-market or private transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Saba Capital Management, L.P.

(Last)(First)(Middle)
405 LEXINGTON AVENUE
58TH FLOOR

(Street)
NEW YORK NEW YORK 10174

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/21/2026P7,087A$10.132,150,793I-
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Saba Capital Management, L.P. By: Zachary Gindes08/24/2026
Boaz Weinstein08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)